-
1
المؤلفون: Tom M. Ganten, M. A. Woerns, Jens T. Siveke, Ulrich M. Lauer, R. Jankowsky, A. Mais, Bernd Hentsch, Henning Wege, B. Hauns, Marius Horger, Edoardo G. Giannini, Matthias M. Dollinger, Vincenzo Montesarchio, Michael Bitzer, Max E. Scheulen, Guido Gerken
المصدر: Journal of Clinical Oncology. 30:262-262
مصطلحات موضوعية: Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, business.industry, Cancer, medicine.disease, Surgery, chemistry.chemical_compound, Tolerability, Resminostat, chemistry, Hepatocellular carcinoma, Internal medicine, medicine, HDAC inhibitor, In patient, business, Progressive disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::15c5121572a995bacc095f3bdb948545Test
https://doi.org/10.1200/jco.2012.30.4_suppl.262Test -
2
المؤلفون: A. Mais, Bernd Hentsch, Guido Gerken, Tom M. Ganten, M. A. Woerns, Jens T. Siveke, Michael Bitzer, Max E. Scheulen, Ulrich M. Lauer, Matthias M. Dollinger, R. Jankowsky, B. Hauns, Marius Horger, Matthias P. Ebert
المصدر: Journal of Clinical Oncology. 29:e13603-e13603
مصطلحات موضوعية: Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, Pathology, business.industry, Cancer, medicine.disease, chemistry.chemical_compound, Phase i ii, Resminostat, chemistry, Internal medicine, Hepatocellular carcinoma, medicine, HDAC inhibitor, In patient, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::aaf83520c05a81a8dd3f3d3e5aa99b67Test
https://doi.org/10.1200/jco.2011.29.15_suppl.e13603Test -
3
المؤلفون: German Aio, Frank T. Kolligs, MP Ebert, M. Kabisch, U. Denzer, Stephan Kanzler, A. W. Lohse, Carl C. Schimanski, U. Lindig, Stefan Zeuzem, Markus Moehler, S. Zimmermann, Frank Lammert, M. A. Woerns, N. Lubomierski, A. Distelrath, Peter R. Galle, E. M. Duerr, Matthias M. Dollinger, Michael Geissler, S. Schadmann-Fischer
المصدر: Journal of Clinical Oncology. 29:4077-4077
مصطلحات موضوعية: Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, Chemotherapy, Biliary tract cancer, business.industry, medicine.medical_treatment, Placebo, Gemcitabine, Surgery, Double blind, Internal medicine, medicine, In patient, business, Chemotherapy naive, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2df7e1f12ff4c7ae3f7f66481d6096e3Test
https://doi.org/10.1200/jco.2011.29.15_suppl.4077Test -
4
المؤلفون: Bernd Hentsch, Matthias P. Ebert, Michael Bitzer, Matthias M. Dollinger, M. A. Woerns, Marius Horger, Tom M. Ganten, A. Mais, B. Hauns, Ulrich M. Lauer
المصدر: Journal of Clinical Oncology. 29:275-275
مصطلحات موضوعية: Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, business.industry, Cancer, Pharmacology, medicine.disease, chemistry.chemical_compound, Resminostat, chemistry, Tolerability, Internal medicine, Hepatocellular carcinoma, Medicine, In patient, Dosing, business, Progressive disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5c9c0dd87d023a8660bb00dbabc1333eTest
https://doi.org/10.1200/jco.2011.29.4_suppl.275Test